CYTOSORBENTS CORPORATION Accounts Payable
CYTOSORBENTS CORPORATION (CTSO) had Accounts Payable of $2.00 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable, Current $2.00M.
- 2026-03-31: Accounts Payable, Current $3.13M.
- 2025-12-31: Accounts Payable, Current $2.87M.
- 2025-09-30: Accounts Payable, Current $3.04M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $3.13M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.87M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $3.04M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $3.39M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.33M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $3.34M 10-K · filed 2026-03-30 | $3.34M 10-K · filed 2025-03-31 |
| 2024-09-30 | $2.34M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.05M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $3.80M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $3.44M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.84M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $1.66M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $2.35M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.13M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $4.83M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $2.81M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.36M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.17M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $1.68M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $1.84M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $2.39M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $2.73M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $2.04M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $2.07M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.15M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $1.84M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.49M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $1.86M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.25M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $2.14M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.24M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $1.29M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.58M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $1.66M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $1.33M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $739.94K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $1.02M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $860.69K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $684.63K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $526.67K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $417.72K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $475.21K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $698.31K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $446.17K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $525.96K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $527.65K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $786.52K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $572.01K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $720.56K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $704.71K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $800.67K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $728.01K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $620.85K 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $647.52K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $675.16K 10-K · filed 2013-04-03 | |
| 2011-09-30 | $784.36K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $832.62K 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $817.70K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |